Anti-S22AN/ SLC22A23/ C6orf85 monoclonal antibody

Anti-S22AN/ SLC22A23/ C6orf85 antibody for FACS & in-vivo assay

Target products collectionGo to SLC22A23/SLC22A23 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1562-Ab-1/ GM-Tg-hg-MP1562-Ab-2Anti-Human SLC22A23 monoclonal antibodyHuman
GM-Tg-rg-MP1562-Ab-1/ GM-Tg-rg-MP1562-Ab-2Anti-Rat SLC22A23 monoclonal antibodyRat
GM-Tg-mg-MP1562-Ab-1/ GM-Tg-mg-MP1562-Ab-2Anti-Mouse SLC22A23 monoclonal antibodyMouse
GM-Tg-cynog-MP1562-Ab-1/ GM-Tg-cynog-MP1562-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC22A23 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1562-Ab-1/ GM-Tg-felg-MP1562-Ab-2Anti-Feline SLC22A23 monoclonal antibodyFeline
GM-Tg-cang-MP1562-Ab-1/ GM-Tg-cang-MP1562-Ab-2Anti-Canine SLC22A23 monoclonal antibodyCanine
GM-Tg-bovg-MP1562-Ab-1/ GM-Tg-bovg-MP1562-Ab-2Anti-Bovine SLC22A23 monoclonal antibodyBovine
GM-Tg-equg-MP1562-Ab-1/ GM-Tg-equg-MP1562-Ab-2Anti-Equine SLC22A23 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1562-Ab-1/ GM-Tg-hg-MP1562-Ab-2; GM-Tg-rg-MP1562-Ab-1/ GM-Tg-rg-MP1562-Ab-2;
GM-Tg-mg-MP1562-Ab-1/ GM-Tg-mg-MP1562-Ab-2; GM-Tg-cynog-MP1562-Ab-1/ GM-Tg-cynog-MP1562-Ab-2;
GM-Tg-felg-MP1562-Ab-1/ GM-Tg-felg-MP1562-Ab-2; GM-Tg-cang-MP1562-Ab-1/ GM-Tg-cang-MP1562-Ab-2;
GM-Tg-bovg-MP1562-Ab-1/ GM-Tg-bovg-MP1562-Ab-2; GM-Tg-equg-MP1562-Ab-1/ GM-Tg-equg-MP1562-Ab-2
Products NameAnti-SLC22A23 monoclonal antibody
Formatmab
Target NameSLC22A23
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC22A23 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S22AN/ SLC22A23/ C6orf85 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1562
    Target NameSLC22A23
    Gene ID63027,73102,64559,708634,608317,101084625,614701,100058363
    Gene Symbol and Synonyms3110004L20Rik,C6orf85,Nritp,SLC22A23
    Uniprot AccessionA1A5C7,Q9QZG1
    Uniprot Entry NameS22AN_HUMAN,S22AN_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137266
    Target ClassificationN/A

    The target: SLC22A23, gene name: SLC22A23, also named as C6orf85. SLC22A23 belongs to a large family of transmembrane proteins that function as uniporters, symporters, and antiporters to transport organic ions across cell membranes (Jacobsson et al., 2007 [PubMed 17714910]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.